293 related articles for article (PubMed ID: 33846253)
21. The first case report of medulloblastoma associated with Tatton-Brown-Rahman syndrome.
Sweeney KJ; Mottolese C; Belot A; Szathmari A; Frappaz D; Lesca G; Putoux A; Di Rocco F
Am J Med Genet A; 2019 Jul; 179(7):1357-1361. PubMed ID: 31066180
[TBL] [Abstract][Full Text] [Related]
22. [Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome].
Martin M F; Díaz S C; Mira O M
Andes Pediatr; 2022 Aug; 93(4):561-567. PubMed ID: 37906855
[TBL] [Abstract][Full Text] [Related]
23. Tatton-Brown-Rahman syndrome: Six individuals with novel features.
Balci TB; Strong A; Kalish JM; Zackai E; Maris JM; Reilly A; Surrey LF; Wertheim GB; Marcadier JL; Graham GE; Carter MT
Am J Med Genet A; 2020 Apr; 182(4):673-680. PubMed ID: 31961069
[TBL] [Abstract][Full Text] [Related]
24. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape.
Weinberg DN; Papillon-Cavanagh S; Chen H; Yue Y; Chen X; Rajagopalan KN; Horth C; McGuire JT; Xu X; Nikbakht H; Lemiesz AE; Marchione DM; Marunde MR; Meiners MJ; Cheek MA; Keogh MC; Bareke E; Djedid A; Harutyunyan AS; Jabado N; Garcia BA; Li H; Allis CD; Majewski J; Lu C
Nature; 2019 Sep; 573(7773):281-286. PubMed ID: 31485078
[TBL] [Abstract][Full Text] [Related]
25. Remethylation of
Ketkar S; Verdoni AM; Smith AM; Bangert CV; Leight ER; Chen DY; Brune MK; Helton NM; Hoock M; George DR; Fronick C; Fulton RS; Ramakrishnan SM; Chang GS; Petti AA; Spencer DH; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3123-3134. PubMed ID: 31996479
[TBL] [Abstract][Full Text] [Related]
26. The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity.
Nguyen TV; Yao S; Wang Y; Rolfe A; Selvaraj A; Darman R; Ke J; Warmuth M; Smith PG; Larsen NA; Yu L; Zhu P; Fekkes P; Vaillancourt FH; Bolduc DM
J Biol Chem; 2019 Nov; 294(45):16966-16977. PubMed ID: 31582562
[TBL] [Abstract][Full Text] [Related]
27. Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases.
Cheng X; Blumenthal RM
Curr Opin Struct Biol; 2022 Aug; 75():102433. PubMed ID: 35914495
[TBL] [Abstract][Full Text] [Related]
28. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
29. Germline DNMT3A mutation in familial acute myeloid leukaemia.
DiNardo CD; Beird HC; Estecio M; Hardikar S; Takahashi K; Bannon SA; Borthakur G; Jabbour E; Gumbs C; Khoury JD; Routbort M; Gong T; Kondo K; Kantarjian H; Garcia-Manero G; Chen T; Futreal PA
Epigenetics; 2021 May; 16(5):567-576. PubMed ID: 32856987
[TBL] [Abstract][Full Text] [Related]
30. Rapid and accurate remethylation of DNA in
Li Y; Abel HJ; Cai M; LaValle TA; Yin T; Helton NM; Smith AM; Miller CA; Ley TJ
Sci Adv; 2024 Feb; 10(5):eadk8598. PubMed ID: 38295174
[TBL] [Abstract][Full Text] [Related]
31. Co-occurrence of a maternally inherited
Polonis K; Blackburn PR; Urrutia RA; Lomberk GA; Kruisselbrink T; Cousin MA; Boczek NJ; Hoppman NL; Babovic-Vuksanovic D; Klee EW; Pichurin PN
Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 29802153
[TBL] [Abstract][Full Text] [Related]
32. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
33. Identification of aberrant transcription termination at specific gene loci with DNA hypomethylated transcription termination sites caused by DNA methyltransferase deficiency.
Shirai M; Nara T; Takahashi H; Takayama K; Chen Y; Hirose Y; Fujii M; Awazu A; Shimoda N; Kikuchi Y
Genes Genet Syst; 2022 Oct; 97(3):139-152. PubMed ID: 35718462
[TBL] [Abstract][Full Text] [Related]
34. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
Russler-Germain DA; Spencer DH; Young MA; Lamprecht TL; Miller CA; Fulton R; Meyer MR; Erdmann-Gilmore P; Townsend RR; Wilson RK; Ley TJ
Cancer Cell; 2014 Apr; 25(4):442-54. PubMed ID: 24656771
[TBL] [Abstract][Full Text] [Related]
35. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.
Yang L; Rodriguez B; Mayle A; Park HJ; Lin X; Luo M; Jeong M; Curry CV; Kim SB; Ruau D; Zhang X; Zhou T; Zhou M; Rebel VI; Challen GA; Gottgens B; Lee JS; Rau R; Li W; Goodell MA
Cancer Cell; 2016 Jun; 29(6):922-934. PubMed ID: 27300438
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.
Glass JL; Hassane D; Wouters BJ; Kunimoto H; Avellino R; Garrett-Bakelman FE; Guryanova OA; Bowman R; Redlich S; Intlekofer AM; Meydan C; Qin T; Fall M; Alonso A; Guzman ML; Valk PJM; Thompson CB; Levine R; Elemento O; Delwel R; Melnick A; Figueroa ME
Cancer Discov; 2017 Aug; 7(8):868-883. PubMed ID: 28408400
[TBL] [Abstract][Full Text] [Related]
37. A Model System for Studying the DNMT3A Hotspot Mutation (DNMT3A
Lu R; Wang J; Ren Z; Yin J; Wang Y; Cai L; Wang GG
Cancer Res; 2019 Jul; 79(14):3583-3594. PubMed ID: 31164355
[TBL] [Abstract][Full Text] [Related]
38. Methylation signatures in clinically variable syndromic disorders: a familial DNMT3A variant in two adults with Tatton-Brown-Rahman syndrome.
Kumps C; D'haenens E; Kerkhof J; McConkey H; Alders M; Sadikovic B; Vanakker OM
Eur J Hum Genet; 2023 Dec; 31(12):1350-1354. PubMed ID: 37736838
[No Abstract] [Full Text] [Related]
39. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
[TBL] [Abstract][Full Text] [Related]
40. Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions.
Heyn P; Logan CV; Fluteau A; Challis RC; Auchynnikava T; Martin CA; Marsh JA; Taglini F; Kilanowski F; Parry DA; Cormier-Daire V; Fong CT; Gibson K; Hwa V; Ibáñez L; Robertson SP; Sebastiani G; Rappsilber J; Allshire RC; Reijns MAM; Dauber A; Sproul D; Jackson AP
Nat Genet; 2019 Jan; 51(1):96-105. PubMed ID: 30478443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
